about
CBP and p300 acetylate PCNA to link its degradation with nucleotide excision repair synthesisPoly(ADP-ribose) polymerase-1 cleavage during apoptosis: an updateAnalysis of poly(ADP-ribose) glycohydrolase activity in nuclear extracts from mammalian cellsDisruptive chemicals, senescence and immortalityEnvironmental immune disruptors, inflammation and cancer riskDisruptive environmental chemicals and cellular mechanisms that confer resistance to cell deathThe effect of environmental chemicals on the tumor microenvironmentThe potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signallingHuman proliferating cell nuclear antigen, poly(ADP-ribose) polymerase-1, and p21waf1/cip1. A dynamic exchange of partnersThe impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisAssessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesisMitochondrial poly(ADP-ribosylation): from old data to new perspectives.Etoposide induces the dispersal of DNA ligase I from replication factoriesRegulation of poly(ADP-ribose) polymerase-1 functions by leukocyte elastase inhibitor/LEI-derived DNase II during caspase-independent apoptosis.New arylthioindoles and related bioisosteres at the sulfur bridging group. 4. Synthesis, tubulin polymerization, cell growth inhibition, and molecular modeling studies.Poly(ADP-ribosylation) and apoptosis.Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot studyA new cell-selective three-dimensional microincubator based on silicon photonic crystals.Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactionsMechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression.Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?Distribution of centromeric proteins and PARP-1 during mitosis and apoptosis.Telomeres, telomerase, and apoptosis.Rearrangement of nuclear ribonucleoprotein (RNP)-containing structures during apoptosis and transcriptional arrest.Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy.Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response.Conversation between apoptosis and autophagy: "Is it your turn or mine?".Poly(ADP-ribosylation) and neoplastic transformation: effect of PARP inhibitors.Berberine: new perspectives for old remedies.Drug treatment of cancer cell lines: a way to select for cancer stem cells?Morphological Features of Organelles during Apoptosis: An Overview.Poly(ADP-ribose): a signaling molecule in different paradigms of cell death.Berberine, an epiphany against cancer.Poly(ADP-ribosylation) and neurodegenerative disorders.Effect of new berberine derivatives on colon cancer cells.Multiple effects of the Na(+)/H (+) antiporter inhibitor HMA on cancer cells.Label-free optical detection of cells grown in 3D silicon microstructures.Characterization of stress response in human retinal epithelial cells.Manipulation of autophagy in cancer cells: an innovative strategy to fight drug resistance.2-Methoxyestradiol: new perspectives in colon carcinoma treatment.
P50
Q24299397-6CEF6B1F-9C52-4362-A111-4A661A097922Q24301005-CCC13700-F648-44BF-A280-6B2D7758098FQ24309657-899A9DD3-E886-4ECD-9459-BED9E0F2CE29Q27026235-D7695C73-04B9-4D6D-A2E9-892C706B534CQ28080870-CAD58689-3133-45CE-8A91-14E282EBD444Q28080874-F72F45BE-ADEF-4C0D-93B9-872F0A8B7FF0Q28085138-F4D1C94A-0290-47BB-8218-AFADA4BFA9EEQ28087571-658A191E-E868-4936-A4A7-18F5C8BC7C19Q28202875-2E4A5B6E-485F-4021-ACBD-D3311266396CQ28388257-1974A715-BF1F-4706-AC53-B6B76BC04289Q28397726-549A0994-40F5-4CB0-9405-41E866C79CD8Q30968173-1CCAA908-D814-4033-8624-8EBF15B13354Q30994856-AC12CD62-F694-4C01-B04A-DC9128057751Q33379457-82642C8C-C06B-499C-B8D9-EAE393475BDCQ33555754-8C690D8A-B98F-4805-A351-DAF635791395Q33764232-76D1AAF8-B460-4FD2-9553-2AD317735C5EQ34427704-AA6E4FC9-9C77-46FE-BD41-9D952595356BQ34472027-89811611-37E8-4F62-A5B5-817456557F30Q34477550-BB4960BF-C302-4118-A861-AD054E8FE360Q34482050-9DDAADF5-06FB-4052-87F1-EF017F38432BQ34482056-8B70B9E3-6D02-477F-9152-777D419C12BEQ35000674-DC0A34F8-A777-49AB-8A58-0A41D9F99715Q35851312-E9D77CBB-A2C1-4A13-94B9-D9F29F9E3091Q35935644-D7BA9170-208D-4C2C-9FA0-38C1EAD7F50CQ36282399-4BE7AE26-1CDB-4A54-9612-499B113E5955Q37680260-1F299EC6-0678-4145-BB9E-239EC4775861Q37853069-07A34BAE-92B4-48B2-A676-22EC79CC9D28Q37994801-15C62B42-FDE5-4BB0-B603-2F22E4AA2F20Q38030353-F6E170D2-4024-44A9-B323-7300AF574818Q38161343-45A359B7-D09A-4687-8917-7E313EA3996EQ38202817-BA40C7AD-A892-4E29-92E2-C14FE944757CQ38224413-1A59CAD0-C917-4F2C-BCCA-9E6A77CC237CQ38242945-979108AE-8523-4BE8-AF6B-BF1FF90E543BQ38551492-7086E8E0-2F18-4177-8178-E94862E659CAQ38837692-BA5486B6-BCFB-41F3-933D-1837FA7BD8FEQ39101411-45253C4B-CDC6-4C4A-AC70-1428D17C3077Q39132005-11C06793-2B34-4E75-84CE-C8C96CD2040BQ39233704-ECB8D21C-2055-44B7-91DC-0BB150862DD0Q39407829-AF385431-1EF2-4B46-887A-9577EF7D4E0BQ39659637-9F3CC480-9F1A-4227-BD37-FF23D07D4DEB
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna Ivana Scovassi
@ast
Anna Ivana Scovassi
@en
Anna Ivana Scovassi
@es
Anna Ivana Scovassi
@nl
type
label
Anna Ivana Scovassi
@ast
Anna Ivana Scovassi
@en
Anna Ivana Scovassi
@es
Anna Ivana Scovassi
@nl
prefLabel
Anna Ivana Scovassi
@ast
Anna Ivana Scovassi
@en
Anna Ivana Scovassi
@es
Anna Ivana Scovassi
@nl
P106
P1153
56055380900
7006237300
P21
P31
P496
0000-0003-3484-9881